ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SBFM Sunshine Biopharma Inc

0.99
0.1826 (22.62%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 32,381,456
Bid Price 0.983
Ask Price 0.99
News -
Day High 1.19

Low
0.75

52 Week Range

High
140.00

Day Low 0.7531
Share Name Share Symbol Market Stock Type
Sunshine Biopharma Inc SBFM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.1826 22.62% 0.99 18:59:59
Open Price Low Price High Price Close Price Previous Close
0.772 0.7531 1.19 0.95 0.8074
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
79,724 32,381,456 US$ 1.02 US$ 33,151,273 - 0.75 - 140.00
Last Trade Type Quantity Price Currency
18:59:59 formt 124 US$ 0.99 USD

Sunshine Biopharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
24.39M 25.68M - 24.09M -4.51M -0.18 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sunshine Biopharma News

Date Time Source News Article
3/06/202415:05Edgar (US Regulatory)Form 8-K - Current report
3/05/202415:37Edgar (US Regulatory)Form PRE 14C - Other preliminary information statements
3/05/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/23/202415:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/21/202415:28Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/21/202407:24Edgar (US Regulatory)Form PRE 14C - Other preliminary information statements
2/16/202416:01Edgar (US Regulatory)Form 8-K - Current report
2/15/202410:39Edgar (US Regulatory)Form 8-K - Current report
2/14/202414:53Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/14/202410:18Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]
2/12/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
2/12/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SBFM Message Board. Create One! See More Posts on SBFM Message Board See More Message Board Posts

Historical SBFM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.342.450.751.209,813,705-1.35-57.69%
1 Month11.1313.250.759.0129,375,238-10.14-91.11%
3 Months24.8426.200.758.1626,514,039-23.85-96.01%
6 Months31.7332.490.758.2812,387,907-30.74-96.88%
1 Year67.01140.000.7512.526,530,846-66.02-98.52%
3 Years275.00987.000.75173.444,525,707-274.01-99.64%
5 Years275.00987.000.75173.444,525,707-274.01-99.64%

Sunshine Biopharma Description

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5).

Your Recent History

Delayed Upgrade Clock